Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram

John Hyttel1, K. Fredricson Overø1, Jørn Arnt1
1Research Laboratories, H. Lundbeck & Co. A/S, Copenhagen-Valby, Denmark

Tóm tắt

Từ khóa


Tài liệu tham khảo

Buckett WR, Strange PG, Stuart EM, Thomas PC (1983) Chronic antidepressant treatment, hormonal manipulation and cortical serotonin S2 receptors. Br J Pharmacol 79:297P

Carlsson A, Corrodi H, Fuxe K, H�kfelt T (1969) Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-?-ethyl-metatyramine. Eur J Pharmacol 5:357?366

Charney DS, Menkes DB, Heninger GR (1981) Receptor sensitivity and the mechanism of action of antidepressant treatment. Arch Gen Psychiatry 38:1160?1180

Cheng Y-C, Prusoff WH (1973) Relationship between the inhibition constant (K i) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099?3108

Coppen A, Rao VAR, Swade C, Wood K (1979) Zimelidine: A therapeutic and pharmacokinetic study in depression. Psychopharmacology 63:199?202

Fredricson Over� K (1981) Fluorescense assay of citalopram and its metabolites in plasma by scanning densitometry of thin-layer chromatograms. J Chromatogr 224:526?531

Fredricson Over� K (1982a) Kinetics of citalopram in test animals: drug exposure in safety studies. Prog Neuro-Psychopharmacol Biol Psychiatry 6:297?309

Fredricson Over� K (1982b) Kinetics of citalopram in man; plasma levels in patients. Prog Neuro-Psychopharmacol Biol Psychiatry 6:311?318

Fuxe K, �gren S-O, Agnati LF, Andersson K, Eneroth P (1982) On the mechanism of action of antidepressant drugs: Indications of a reduction in 5-HT neurotransmission in some brain regions upon subchronic treatment. In: Langer SZ, Takahashi R, Segawa T, Briley M (eds) New vistas in depression. Advances in the Biosciences, vol 40. Pergamon Press, Oxford, pp 49?63

Gastpar M, Gastpar G (1982) Preliminary studies with citalopram (Lu 10-171), a specific 5-HT-reuptake inhibitor, as antidepressant. Prog Neuro-Psychopharmacol Biol Psychiatry 6:319?325

Gottlieb P, Wandall T, Fredricson Over� K (1980) Initial, clinical trial of a new, specific 5-HT reuptake inhibitor, citalopram (Lu 10-171). Acta Psychiatr Scand 62:236?244

Horn AS, Phillipson OT (1976) A noradrenaline sensitive adenylate cyclase in the rat limbic forebrain: Preparations, properties and the effects of agonists, adrenolytics and neuroleptic drugs. Eur J Pharmacol 37:1?11

Hwang EC, Van Woert MH (1980) Acute versus chronic effect of serotonin uptake blockers on potentiation of the ?serotonin syndrome?. Commun Psychopharmacol 4:161?167

Hyttel J (1977) Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-17. Psychopharmacology 51:225?233

Hyttel J (1978) Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro. Psychopharmacology 60:13?18

Hyttel J (1982) Citalopram ? Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuro-Psychopharmacol Biol Psychiatry 6:277?295

Hyttel J, Fjalland B (1972) Central 5-HT decarboxylase inhibiting properties of Ro 4-4602 in relation to 5-HTP potentiation in mice. Eur J Pharmacol 19:112?114

Kragh-S�rensen P (1983) A controlled, double-blind multicentre trial comparing clomipramine and a new, highly selective 5-HT uptake inhibitor, citalopram (Lu 10-171). Abstract. VII World Congress in Psychiatry, Vienna. July 11?16, 1983, p 482

Kragh-S�rensen P, Fredricson Over� K, Lindegaard Petersen O, Jensen K, Parnas W (1981) The kinetics of citalopram: Single and multiple dose studies in man. Acta Pharmacol Toxicol 48:53?60

Klein DF, Davis JM (1969) Treatment of affective disorders. In: Diagnosis and drug treatment of psychiatric disorders. Williams & Wilkins Company, Baltimore, pp 299?322

Lindegaard Pedersen O, Kragh-S�rensen P, Bjerre M, Fredricson Over� K, Gram LF (1982) Citalopram, a selective serotonin reuptake inhibitor, clinical antidepressive and long term effect ? A phase II study. Psychopharmacology 77:199?204

Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265?275

Mertens C (1983) A controlled double-blind clinical trial with a new highly selective 5-HT-re-uptake inhibitor, citalopram (Lu 10-171) versus mianserin in depressed patients. Abstract. VII World Congress of Psychiatry, Vienna. July 11?16, 1983, p 441

Miller I, Freund JE (1965) Probability and statistics for engineers. Prentice-Hall, Inc., New Jersey, p 174

Mishra R, Janowsky A, Sulser F (1979) Subsensitivity of the norepinephrine receptor-coupled adenylate cyclase system in brain: Effects of nisoxetine versus fluoxetine. Eur J Pharmacol 60:379?382

Mishra R, Janowsky A, Sulser F (1980) Action of mianserin and zimelidine on the norepinephrine receptor coupled adenylate cyclase system in brain: Subsensitivity without reduction in ?-adrenergic receptor binding. Neuropharmacology 19:983?987

Oswald I, Brezinova V, Dunleavy DLF (1972) On the slowness of action of tricyclic antidepressant drugs. Br J Psychiatry 120:673?677

Peroutka SJ, Snyder SH (1980) Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210:88?90

Ross SB, Hall H, Renyi AL, Westerlund D (1981) Effects of zimelidine on serotoninergic and noradrenergic neurons after repeated administration in the rat. Psychopharmacology 72:219?225

Sethy VH, Harris DW (1981) Effect of norepinephrine uptake blocker on ?-adrenergic receptors of the rat cerebral cortex. Eur J Pharmacol 75:53?56

Snyder SH, Peroutka SJ (1982) A possible role of serotonin receptors in antidepressant drug action. Pharmacopsychiatry 15:131?134

Sugrue MF (1981) Current concepts on the mechanisms of action of antidepressant drugs. Pharmacol Ther 13:219?247

Sulser F, Mishra R (1982) Regulation of central noradrenergic receptor function and its relevance to the therapy of depression. In: Langer SZ, Takahashi R, Segawa T, Briley M (eds) New Vistas in Depression. Advances in the biosciences, vol 40. Pergamon Press, Oxford, pp 37?47

Van der Waerden BL, Nievergelt E (1956) Tables for comparing two samples by X-test and sign test. Springer, Berlin G�ttingen Heidelberg, pp 22?25

Yuwiler A, Plotkin S, Geller E, Ritvo ER (1970) A rapid accurate procedure for the determination of serotonin in whole human blood. Biochem Med 3:426?431

Zivin JA, Waud DR (1982) How to analyze binding, enzyme and uptake data: The simplest case, a single phase. Life Sci 30:1407?1422

�fsti E (1982) Citalopram ? a specific 5-HT-reuptake inhibitor ?as an antidepressant drug: A phase II multicentre trial. Prog Neuro-Psychopharmacol Biol Psychiatry 6:327?335

�berg-Wisted A (1982) A doubld-blind study of zimeline, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings. Acta Psychiatr Scand 66:50?65